Unknown

Dataset Information

0

Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis.


ABSTRACT: Phosphate binders are the main treatment for hyperphosphatemia in patients with chronic kidney disease, and iron-based phosphate binders have been used with increasing frequency in recent years. This study examined the association of the use of iron-based, rather than non-iron-based, phosphate binders with the incidence of cardiovascular events, in a real-world setting. We used data from a cohort comprising representative adult patients on maintenance hemodialysis in Japan. The exposure of interest was the time-varying use of phosphate binders, classified into "iron-based", "only non-iron-based", and "no use". The primary outcome was a composite of cardiovascular events and all-cause deaths. A marginal structural Cox regression model was used to deal with possible time-dependent confounding. Of the 2247 patients from 58 hemodialysis facilities, iron-based and only non-iron-based phosphate binders were used in 328 (15%) and 1360 (61%), respectively, at baseline. Hazard ratios (95% confidence intervals) for iron-based and non-iron-based phosphate binders versus no use of phosphate binders were 0.35 (0.24, 0.52) and 0.44 (0.33, 0.58), respectively. The hazard ratio for iron-based relative to non-iron-based phosphate binders was 0.81 (0.58, 1.13), which was not statistically significant. Further studies are warranted to elucidate whether the use of iron-based phosphate binders reduces the event rate.

SUBMITTER: Tanaka A 

PROVIDER: S-EPMC10520071 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis.

Tanaka Akihito A   Sasaki Sho S   Noma Hisashi H   Wang Jui J   Onishi Yoshihiro Y   Inaguma Daijo D  

Scientific reports 20230925 1


Phosphate binders are the main treatment for hyperphosphatemia in patients with chronic kidney disease, and iron-based phosphate binders have been used with increasing frequency in recent years. This study examined the association of the use of iron-based, rather than non-iron-based, phosphate binders with the incidence of cardiovascular events, in a real-world setting. We used data from a cohort comprising representative adult patients on maintenance hemodialysis in Japan. The exposure of inter  ...[more]

Similar Datasets

| S-EPMC7598463 | biostudies-literature
| S-EPMC7170300 | biostudies-literature
| S-EPMC8791353 | biostudies-literature
| S-EPMC7325317 | biostudies-literature
| S-EPMC8106029 | biostudies-literature
| S-EPMC8259655 | biostudies-literature
| S-EPMC6705850 | biostudies-literature
| S-EPMC3783620 | biostudies-literature
| S-EPMC4538050 | biostudies-literature
| S-EPMC9529177 | biostudies-literature